Ascend Gene & Cell Therapies
Initial Transaction Details
Transaction Date
February 2023
Purpose of Financing
Venture
Stage of Company
Early Stage
Structure of Financing
Equity
Ascend is a specialist company innovating manufacturing processes to improve quality, potency, safety and cost enabling better reach for gene therapy technologies, initially focused on high-quality Adeno-associated virus (AAV) vectors. Ascend offers process development, clinical manufacturing, and analytical and regulatory support for biotech companies working in advanced modalities requiring flexible CMC services.
Website